The Roles of SUMO in Metabolic Regulation.

Protein modification with the small ubiquitin-related modifier (SUMO) can affect protein function, enzyme activity, protein-protein interactions, protein stability, protein targeting and cellular localization. SUMO influences the function and regulation of metabolic enzymes within pathways, and in some cases targets entire metabolic pathways by affecting the activity of transcription factors or by facilitating the translocation of entire metabolic pathways to subcellular compartments. SUMO modification is also a key component of nutrient- and metabolic-sensing mechanisms that regulate cellular metabolism. In addition to its established roles in maintaining metabolic homeostasis, there is increasing evidence that SUMO is a key factor in facilitating cellular stress responses through the regulation and/or adaptation of the most fundamental metabolic processes, including energy and nucleotide metabolism. This review focuses on the role of SUMO in cellular metabolism and metabolic disease.

[1]  H. Waterham,et al.  A lethal defect of mitochondrial and peroxisomal fission. , 2007, The New England journal of medicine.

[2]  K. Keyomarsi,et al.  Molecular Cloning, Characterization, and Regulation of the Human Mitochondrial Serine Hydroxymethyltransferase Gene* , 1997, The Journal of Biological Chemistry.

[3]  H. Ingraham,et al.  The DEAD-Box Protein DP103 (Ddx20 or Gemin-3) Represses Orphan Nuclear Receptor Activity via SUMO Modification , 2005, Molecular and Cellular Biology.

[4]  K. Wells,et al.  Global shifts in protein sumoylation in response to electrophile and oxidative stress. , 2004, Chemical research in toxicology.

[5]  H. McBride,et al.  The SUMO protease SENP5 is required to maintain mitochondrial morphology and function , 2007, Journal of Cell Science.

[6]  E. Yeh,et al.  PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia , 2010, Oncogene.

[7]  T. Ohshima,et al.  Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ Is Modulated by SUMO-1 Modification* , 2004, Journal of Biological Chemistry.

[8]  H. McBride,et al.  MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission , 2009, EMBO reports.

[9]  C. Tasca,et al.  Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways , 2015, Neurochemical Research.

[10]  J. Henley,et al.  Increased protein SUMOylation following focal cerebral ischemia , 2008, Neuropharmacology.

[11]  J. Auwerx,et al.  Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. , 2011, The American journal of clinical nutrition.

[12]  P. Stover,et al.  Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.

[13]  T. Osumi,et al.  The transactivating function of peroxisome proliferator‐activated receptor γ is negatively regulated by SUMO conjugation in the amino‐terminal domain , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[14]  Kyu-Won Kim,et al.  Sumoylation increases HIF-1α stability and its transcriptional activity , 2004 .

[15]  Mary B. Kroetz,et al.  Identification of SUMO-interacting proteins by yeast two-hybrid analysis. , 2009, Methods in molecular biology.

[16]  H. McBride,et al.  Sumo1 Conjugates Mitochondrial Substrates and Participates in Mitochondrial Fission , 2004, Current Biology.

[17]  A. Vertegaal,et al.  Mapping the SUMOylated landscape , 2015, The FEBS journal.

[18]  A. Dejean,et al.  Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. , 2003, Molecular endocrinology.

[19]  P. MacDonald,et al.  Novel roles of SUMO in pancreatic β-cells: thinking outside the nucleus. , 2012, Canadian journal of physiology and pharmacology.

[20]  M. Post,et al.  Dynamic regulation of HIF1Α stability by SUMO2/3 and SENP3 in the human placenta. , 2016, Placenta.

[21]  S. Miyamoto,et al.  Expanding NFκB and SUMO ties , 2011, Cell cycle.

[22]  E. Treuter,et al.  Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. , 2011, Biochimica et biophysica acta.

[23]  Ping Huang,et al.  A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors* , 2012, The Journal of Biological Chemistry.

[24]  G. Cagney,et al.  Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia* , 2010, The Journal of Biological Chemistry.

[25]  G. Barton,et al.  Proteotoxic stress reprograms the chromatin landscape of SUMO modification , 2015, Science Signaling.

[26]  J. Abe,et al.  Kinase-SUMO networks in diabetes-mediated cardiovascular disease. , 2016, Metabolism: clinical and experimental.

[27]  R. Trembath,et al.  A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. , 2002, Human molecular genetics.

[28]  I. Matic,et al.  Proteome-wide identification of SUMO modification sites by mass spectrometry , 2015, Nature Protocols.

[29]  R. Uzbekov,et al.  Inhibition of Pathogenic Mutant SOD1 Aggregation in Cultured Motor Neuronal Cells by Prevention of Its SUMOylation on Lysine 75 , 2015, Neurodegenerative Diseases.

[30]  Dong-Hyun Kim,et al.  A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity , 2015, The EMBO journal.

[31]  J. Chan,et al.  Sumoylation of Hypoxia-Inducible Factor-1α Ameliorates Failure of Brain Stem Cardiovascular Regulation in Experimental Brain Death , 2011, PloS one.

[32]  Tao Yang,et al.  Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats , 2013, Inflammation Research.

[33]  Jeff S. Jasper,et al.  ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer. , 2016, Cell reports.

[34]  C. Blackstone,et al.  Cyclic AMP-dependent Protein Kinase Phosphorylation of Drp1 Regulates Its GTPase Activity and Mitochondrial Morphology* , 2007, Journal of Biological Chemistry.

[35]  J. Goldstein,et al.  Erratum: Cholesterol feedback: From Schoenheimer's bottle to Scap's MELADL (Journal of Lipid Research (2009) 50 (S15-S27)) , 2009 .

[36]  P. MacDonald,et al.  SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets. , 2014, American journal of physiology. Endocrinology and metabolism.

[37]  Vincent Laudet,et al.  Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.

[38]  J. Elmquist,et al.  Nutritional conditions regulate transcriptional activity of SF-1 by controlling sumoylation and ubiquitination , 2016, Scientific Reports.

[39]  Katherine L. Herbig,et al.  Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.

[40]  H. de Thé,et al.  PML nuclear bodies: Assembly and oxidative stress-sensitive sumoylation , 2014, Nucleus.

[41]  M. Lovett,et al.  Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. , 2000, American journal of human genetics.

[42]  Xiaoyang Wang,et al.  Increase of SUMO‐1 expression in response to hypoxia: direct interaction with HIF‐1α in adult mouse brain and heart in vivo , 2004, FEBS letters.

[43]  Prashant Mishra,et al.  Mitochondrial dynamics and inheritance during cell division, development and disease , 2014, Nature Reviews Molecular Cell Biology.

[44]  S. Padma,et al.  Detection of atypical metastases in recurrent adenoid cystic carcinoma of parotid gland. , 2013, Journal of cancer research and therapeutics.

[45]  P. Stover,et al.  Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA Synthesis* , 2012, The Journal of Biological Chemistry.

[46]  P. Neufer,et al.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. , 2015, The Journal of clinical investigation.

[47]  P. Stover,et al.  Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase , 2007, Clinical chemistry and laboratory medicine.

[48]  S. H. Baek,et al.  Negative Modulation of RXRα Transcriptional Activity by Small Ubiquitin-related Modifier (SUMO) Modification and Its Reversal by SUMO-specific Protease SUSP1* , 2006, Journal of Biological Chemistry.

[49]  P. Stover,et al.  SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis , 2009, PloS one.

[50]  P. Stover,et al.  Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis , 2014, Proceedings of the National Academy of Sciences.

[51]  C. Glass,et al.  Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors , 1997, Molecular and cellular biology.

[52]  K. Schoonjans,et al.  Molecular basis for the regulation of the nuclear receptor LRH-1. , 2015, Current opinion in cell biology.

[53]  F. Giorgino,et al.  The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Hallenbeck,et al.  Protein SUMOylation is Massively Increased in Hibernation Torpor and is Critical for the Cytoprotection Provided by Ischemic Preconditioning and Hypothermia in SHSY5Y Cells , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  M. Mann,et al.  Uncovering Global SUMOylation Signaling Networks in a Site-Specific Manner , 2014, Nature Structural &Molecular Biology.

[56]  H. McBride,et al.  MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death. , 2015, Molecular cell.

[57]  L. Martiniova,et al.  Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects. , 2015, The American journal of clinical nutrition.

[58]  Timothy F. Osborne,et al.  SREBPs: metabolic integrators in physiology and metabolism , 2012, Trends in Endocrinology & Metabolism.

[59]  H. Cimarosti,et al.  SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease? , 2015, Aging and disease.

[60]  Jennifer J. Lund,et al.  SUMO1 Haploinsufficiency Leads to Cleft Lip and Palate , 2006, Science.

[61]  Jennifer T. Fox,et al.  Mechanism of the Internal Ribosome Entry Site-mediated Translation of Serine Hydroxymethyltransferase 1* , 2009, The Journal of Biological Chemistry.

[62]  Brian J. Wilson,et al.  Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. , 2008, Molecular endocrinology.

[63]  B. Brüne,et al.  Sumoylation of Peroxisome Proliferator-Activated Receptor γ by Apoptotic Cells Prevents Lipopolysaccharide-Induced NCoR Removal from κB Binding Sites Mediating Transrepression of Proinflammatory Cytokines1 , 2008, The Journal of Immunology.

[64]  M. Dasso,et al.  Modification in reverse: the SUMO proteases. , 2007, Trends in biochemical sciences.

[65]  T. Osumi,et al.  Aspects of the regulatory mechanisms of PPAR functions: Analysis of a bidirectional response element and regulation by sumoylation , 2006, Molecular and Cellular Biochemistry.

[66]  E. Ravussin,et al.  Mitochondrial energetics and insulin resistance. , 2008, Endocrinology.

[67]  Sebastian A. Wagner,et al.  Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. , 2015, DNA repair.

[68]  Christopher M Hickey,et al.  Function and regulation of SUMO proteases , 2012, Nature Reviews Molecular Cell Biology.

[69]  B. Grygiel-Górniak Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.

[70]  R. Kraus,et al.  Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. , 2007, Biochemistry.

[71]  M. Asaka,et al.  PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability. , 2016, Biochemical and biophysical research communications.

[72]  P. MacDonald,et al.  Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. , 2015, Cell reports.

[73]  X. Deng,et al.  Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity. , 2014, Biochemical and biophysical research communications.

[74]  Li Wang,et al.  SUMO1 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate. , 2008, Biochemical and biophysical research communications.

[75]  Peter J. Keller,et al.  SUMOylation of the mitochondrial fission protein Drpl occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  Katrin Eckermann,et al.  SUMO and Parkinson’s Disease , 2013, NeuroMolecular Medicine.

[77]  E. Vivés,et al.  SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation , 2014, Oncogene.

[78]  J. Goldstein,et al.  A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.

[79]  P. Möller,et al.  SUMOylation Attenuates the Transcriptional Activity of the NF‐κB Subunit RelB , 2014, Journal of cellular biochemistry.

[80]  P. Stover,et al.  Nuclear Localization of de Novo Thymidylate Biosynthesis Pathway Is Required to Prevent Uracil Accumulation in DNA* , 2011, Journal of Biological Chemistry.

[81]  Yong Xu,et al.  High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells. , 2013, Biochemical and biophysical research communications.

[82]  Jun Wang,et al.  Defective sumoylation pathway directs congenital heart disease. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[83]  H. McBride,et al.  Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death , 2007, The Journal of cell biology.

[84]  M. Brosnan,et al.  Nuclear Enrichment of Folate Cofactors and Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) Protect de Novo Thymidylate Biosynthesis during Folate Deficiency* , 2014, The Journal of Biological Chemistry.

[85]  S. Kersten Integrated physiology and systems biology of PPARα , 2014, Molecular metabolism.

[86]  M. Willis,et al.  The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. , 2012, American journal of physiology. Heart and circulatory physiology.

[87]  Ivan Dikic,et al.  Specification of SUMO1- and SUMO2-interacting Motifs* , 2006, Journal of Biological Chemistry.

[88]  K. Sarge,et al.  Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies , 2008, The Journal of cell biology.

[89]  R. Evans,et al.  PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis , 2007, Proceedings of the National Academy of Sciences.

[90]  S. Kato,et al.  Coactivation of the N-terminal Transactivation of Mineralocorticoid Receptor by Ubc9* , 2007, Journal of Biological Chemistry.

[91]  K. Wilson,et al.  Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy–causing mutations , 2013, Molecular biology of the cell.

[92]  Pierre Thibault,et al.  Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling , 2014, Nature Communications.

[93]  Samir Karaca,et al.  Detecting endogenous SUMO targets in mammalian cells and tissues , 2013, Nature Structural &Molecular Biology.

[94]  F. Melchior,et al.  Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor , 2007, Molecular and Cellular Endocrinology.

[95]  S. Kügler,et al.  Sumoylation inhibits α-synuclein aggregation and toxicity , 2011, The Journal of cell biology.

[96]  C. Blackstone,et al.  A Lethal de Novo Mutation in the Middle Domain of the Dynamin-related GTPase Drp1 Impairs Higher Order Assembly and Mitochondrial Division* , 2010, The Journal of Biological Chemistry.

[97]  I. Matic,et al.  Proteome-Wide Identification of SUMO2 Modification Sites , 2014, Science Signaling.

[98]  D. Maric,et al.  SUMOylation participates in induction of ischemic tolerance , 2009, Journal of neurochemistry.

[99]  P. MacDonald,et al.  SUMO1 enhances cAMP‐dependent exocytosis and glucagon secretion from pancreatic α‐cells , 2014, The Journal of physiology.

[100]  P. Stover,et al.  Trafficking of intracellular folates. , 2011, Advances in nutrition.

[101]  B. Goodpaster Mitochondrial Deficiency Is Associated With Insulin Resistance , 2013, Diabetes.

[102]  S. Müller,et al.  Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5 , 2006, Nature Cell Biology.

[103]  H. de Thé,et al.  Acute promyelocytic leukemia, arsenic, and PML bodies , 2012, The Journal of cell biology.

[104]  G. Barton,et al.  System-Wide Changes to SUMO Modifications in Response to Heat Shock , 2009, Science Signaling.

[105]  Shu Guo,et al.  SUMO1 genetic polymorphisms may contribute to the risk of nonsyndromic cleft lip with or without palate: a meta-analysis. , 2014, Genetic testing and molecular biomarkers.

[106]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[107]  Zhixin Wu,et al.  The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury , 2014, Molecular Neurobiology.

[108]  R. Youle,et al.  Mitochondrial dynamics and apoptosis. , 2008, Genes & development.

[109]  Michael Schuler,et al.  PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes , 2006 .

[110]  Ville Paakinaho,et al.  Electrophilic Lipid Mediator 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Glucocorticoid Signaling via Receptor SUMOylation , 2014, Molecular and Cellular Biology.

[111]  F. Melchior,et al.  Sumoylation: a regulatory protein modification in health and disease. , 2013, Annual review of biochemistry.

[112]  Keiji Tanaka,et al.  Sterol Regulatory Element-binding Proteins Are Negatively Regulated through SUMO-1 Modification Independent of the Ubiquitin/26 S Proteasome Pathway* , 2003, The Journal of Biological Chemistry.

[113]  Tharan Srikumar,et al.  Global map of SUMO function revealed by protein-protein interaction and genetic networks. , 2009, Molecular cell.

[114]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[115]  R. Evans,et al.  Regulation of Muscle Fiber Type and Running Endurance by PPARδ , 2004, PLoS biology.

[116]  J. Henley,et al.  SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia , 2013, The EMBO journal.

[117]  Sumo and the cellular stress response , 2015, Cell Division.

[118]  J. Kemper Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications. , 2011, Biochimica et biophysica acta.

[119]  F. Melchior,et al.  Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. , 2006, Molecular cell.

[120]  E. Joe,et al.  Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. , 2009, Molecular cell.

[121]  A. Sharrocks,et al.  Emerging roles of SUMO modification in arthritis. , 2010, Gene.

[122]  P. Stover,et al.  Cytoplasmic Serine Hydroxymethyltransferase Regulates the Metabolic Partitioning of Methylenetetrahydrofolate but Is Not Essential in Mice* , 2008, Journal of Biological Chemistry.

[123]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[124]  J. Henley,et al.  Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model , 2011, Neuroscience Letters.

[125]  T. Osumi,et al.  Lamin A reassembly at the end of mitosis is regulated by its SUMO-interacting motif. , 2016, Experimental cell research.

[126]  O. Warburg,et al.  The Metabolism of Carcinoma Cells , 1925 .

[127]  M. Hermann,et al.  The SUMO‐E3 ligase PIAS3 targets pyruvate kinase M2 , 2009, Journal of cellular biochemistry.

[128]  R. Prediger,et al.  SUMO‐regulated mitochondrial function in Parkinson's disease , 2016, Journal of neurochemistry.

[129]  E. Berra,et al.  Deciphering the emerging role of SUMO conjugation in the hypoxia-signaling cascade , 2013, Biological chemistry.

[130]  Chu-Tse Wu,et al.  SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling. , 2015, Biochemical and biophysical research communications.

[131]  J. She,et al.  SUMO4 and its role in type 1 diabetes pathogenesis , 2008, Diabetes/metabolism research and reviews.

[132]  F. Suchy,et al.  SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes* , 2013, The Journal of Biological Chemistry.

[133]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[134]  P. Stover,et al.  Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus* , 2011, The Journal of Biological Chemistry.

[135]  S. Jentsch,et al.  Control of nuclear activities by substrate-selective and protein-group SUMOylation. , 2013, Annual review of genetics.

[136]  J. Henley,et al.  Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response , 2014, IUBMB life.

[137]  Shang-Yi Chiu,et al.  Disruption of SUMO-Specific Protease 2 Induces Mitochondria Mediated Neurodegeneration , 2014, PLoS genetics.

[138]  Lily S. Cheung,et al.  Transport of sugars. , 2015, Annual review of biochemistry.

[139]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[140]  P. Chambon,et al.  Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex , 2015, Proceedings of the National Academy of Sciences.

[141]  V. Yang,et al.  SUMOylation Regulates Nuclear Localization of Krüppel-like Factor 5* , 2008, Journal of Biological Chemistry.

[142]  K. Borden,et al.  Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies , 2002, Molecular and Cellular Biology.

[143]  E. Yeh,et al.  Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins* , 1998, The Journal of Biological Chemistry.

[144]  T. Brody,et al.  Subcellular localization of γ-glutamyl carboxypeptidase and of folates , 1976 .

[145]  J. She,et al.  SUMO wrestling with type 1 diabetes , 2005, Journal of Molecular Medicine.

[146]  S. Müller,et al.  Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in β-cells , 2004, The Journal of cell biology.

[147]  D. Klimanis,et al.  Global SUMOylation is a molecular mechanism underlying hypothermia-induced ischemic tolerance , 2014, Front. Cell. Neurosci..

[148]  Jongkyeong Chung,et al.  PIASy-Mediated Sumoylation of SREBP1c Regulates Hepatic Lipid Metabolism upon Fasting Signaling , 2013, Molecular and Cellular Biology.

[149]  K. Sarge,et al.  Sumoylation and human disease pathogenesis. , 2009, Trends in biochemical sciences.

[150]  R. Hay,et al.  SUMO-specific proteases: a twist in the tail. , 2007, Trends in cell biology.

[151]  S. Xue,et al.  SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. , 2014, Cardiovascular research.

[152]  H. Büeler Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease , 2010, Apoptosis.

[153]  P. Stover,et al.  Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway* , 2007, Journal of Biological Chemistry.

[154]  P. Cossart,et al.  Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli , 2014, Proceedings of the National Academy of Sciences.

[155]  E. Yeh,et al.  SUMOylation and De-SUMOylation: Wrestling with Life's Processes* , 2009, Journal of Biological Chemistry.

[156]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[157]  N. Subbarao,et al.  Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function , 2016, Molecular and Cellular Endocrinology.

[158]  O. Shirihai,et al.  Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. , 2008, Biochimica et biophysica acta.

[159]  P. Stover,et al.  Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. , 2011, The American journal of clinical nutrition.

[160]  J. Hallenbeck,et al.  SUMO and Ischemic Tolerance , 2013, NeuroMolecular Medicine.

[161]  A. M. van der Bliek,et al.  Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. , 2001, Molecular biology of the cell.

[162]  Judy Yan,et al.  PKM2 contributes to cancer metabolism. , 2015, Cancer letters.

[163]  C. Nofziger,et al.  Targeting SREBPs for treatment of the metabolic syndrome. , 2015, Trends in pharmacological sciences.

[164]  Per Stehmeier,et al.  Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. , 2009, Molecular cell.

[165]  B. Thorens,et al.  Glucose transporters in the 21st Century. , 2010, American journal of physiology. Endocrinology and metabolism.

[166]  M. Caudill,et al.  Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. , 2012, The American journal of clinical nutrition.

[167]  G. Semenza,et al.  Emerging roles of PKM2 in cell metabolism and cancer progression , 2012, Trends in Endocrinology & Metabolism.

[168]  R. Hegele,et al.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. , 2000, Human molecular genetics.

[169]  Eun Mi Kim,et al.  The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus. , 2011, Molecular immunology.

[170]  Sumoylation of Critical Proteins in Amyotrophic Lateral Sclerosis: Emerging Pathways of Pathogenesis , 2013, NeuroMolecular Medicine.

[171]  Toshihiko Oka,et al.  Mitotic Phosphorylation of Dynamin-related GTPase Drp1 Participates in Mitochondrial Fission* , 2007, Journal of Biological Chemistry.

[172]  T. Niikura,et al.  SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants , 2014, PloS one.

[173]  Divya Subramonian,et al.  Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis. , 2014, Journal of proteome research.

[174]  E. Yeh,et al.  Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.

[175]  Amir Gamliel,et al.  A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.

[176]  T. Williams,et al.  A SUMO-acetyl switch in PXR biology. , 2016, Biochimica et biophysica acta.

[177]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[178]  K. Park,et al.  SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes. , 2011, The Biochemical journal.

[179]  Jingde Zhu,et al.  Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3 , 2005, Oncogene.

[180]  F. Holsboer,et al.  RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity , 2013, Molecular and Cellular Biology.

[181]  Michael D. Schneider,et al.  Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.

[182]  Anselm H. C. Horn,et al.  Binding properties of SUMO-interacting motifs (SIMs) in yeast , 2015, Journal of Molecular Modeling.

[183]  J. Staudinger,et al.  Pregnane X Receptor Is SUMOylated to Repress the Inflammatory Response , 2010, Journal of Pharmacology and Experimental Therapeutics.

[184]  T. Willson,et al.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. , 2007, Molecular cell.

[185]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[186]  L. Weber,et al.  Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. , 2004, World journal of gastroenterology.

[187]  P. Zhu,et al.  Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic beta cells. , 2014, American journal of translational research.

[188]  M. Vázquez-Carrera Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease , 2016, Trends in Endocrinology & Metabolism.

[189]  D. Sabatini,et al.  SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance , 2015 .

[190]  Q. Ao,et al.  SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α , 2015, Scientific Reports.

[191]  D. Hwang,et al.  SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle , 2015, Diabetes.

[192]  O. Arancio,et al.  Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease , 2014, Scientific Reports.

[193]  S. Cortassa,et al.  Mitochondrial and cellular mechanisms for managing lipid excess , 2014, Front. Physiol..

[194]  C. Mathews Deoxyribonucleotide metabolism, mutagenesis and cancer , 2015, Nature Reviews Cancer.

[195]  P. MacDonald,et al.  SUMOylation Regulates Insulin Exocytosis Downstream of Secretory Granule Docking in Rodents and Humans , 2011, Diabetes.

[196]  J. Palvimo,et al.  SUMOylation Attenuates the Function of PGC-1α* , 2009, The Journal of Biological Chemistry.

[197]  H. de Thé,et al.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence , 2015, Proceedings of the National Academy of Sciences.

[198]  T. Suuronen,et al.  Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.

[199]  G. Suske,et al.  Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation Function 1 (AF1) Domain , 2013, PloS one.

[200]  P. Fraser,et al.  SUMO on the road to neurodegeneration. , 2007, Biochimica et biophysica acta.

[201]  T. Wai,et al.  Mitochondrial Dynamics and Metabolic Regulation , 2016, Trends in Endocrinology & Metabolism.

[202]  Rosa Bernardi,et al.  Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies , 2007, Nature Reviews Molecular Cell Biology.

[203]  W. Paschen,et al.  Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. , 2012, Journal of proteome research.

[204]  W. Paschen,et al.  SUMO proteomics to decipher the SUMO‐modified proteome regulated by various diseases , 2015, Proteomics.

[205]  Mitsuru Ohsugi,et al.  SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-δ , 2008, Nature Medicine.

[206]  I. Matic,et al.  Purification and identification of endogenous polySUMO conjugates , 2011, EMBO reports.

[207]  D. Stojanovski,et al.  Mitochondrial morphology and distribution in mammalian cells , 2006, Biological chemistry.

[208]  J. Gustafsson,et al.  GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. , 2010, Genes & development.

[209]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[210]  W. Wahli,et al.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. , 2009, The Journal of clinical investigation.

[211]  M. Shirakawa,et al.  Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. , 2004, Molecular endocrinology.

[212]  M. Nakao,et al.  The Aryl Hydrocarbon Receptor Nuclear Transporter Is Modulated by the SUMO-1 Conjugation System* , 2002, The Journal of Biological Chemistry.

[213]  C. Glass,et al.  Coronin2A mediates actin-dependent de-repression of inflammatory response genes , 2011, Nature.

[214]  F. Filipp Cancer metabolism meets systems biology: Pyruvate kinase isoform PKM2 is a metabolic master regulator , 2013, Journal of carcinogenesis.

[215]  Satoshi Hachimura,et al.  Growth Factor-induced Phosphorylation of Sterol Regulatory Element-binding Proteins Inhibits Sumoylation, Thereby Stimulating the Expression of Their Target Genes, Low Density Lipoprotein Uptake, and Lipid Synthesis* , 2008, Journal of Biological Chemistry.

[216]  Jaclyn R. Gareau,et al.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition , 2010, Nature Reviews Molecular Cell Biology.

[217]  P. Chambon,et al.  GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression , 2015, Proceedings of the National Academy of Sciences.

[218]  Xiaoping Zhou,et al.  Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism , 2013, PloS one.

[219]  M. Mann,et al.  System-wide identification of wild-type SUMO-2 conjugation sites , 2015, Nature Communications.

[220]  P. Reddy,et al.  Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases , 2011, Brain Research Reviews.

[221]  Huilin Zhou,et al.  Global Analyses of Sumoylated Proteins in Saccharomyces cerevisiae , 2004, Journal of Biological Chemistry.

[222]  B. Staels,et al.  SUMOylation of Human Peroxisome Proliferator-activated Receptor α Inhibits Its Trans-activity through the Recruitment of the Nuclear Corepressor NCoR* , 2009, The Journal of Biological Chemistry.

[223]  P. Fraser,et al.  SUMO and Alzheimer’s Disease , 2013, NeuroMolecular Medicine.

[224]  Keiji Tanaka,et al.  The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation , 2016, EMBO reports.

[225]  W. Paschen,et al.  Transient Focal Cerebral Ischemia Induces a Dramatic Activation of Small Ubiquitin-Like Modifier Conjugation , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[226]  J. Henley,et al.  Mechanisms, regulation and consequences of protein SUMOylation. , 2010, The Biochemical journal.

[227]  P. Fraser,et al.  Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. , 2007, The Biochemical journal.

[228]  P. Stover,et al.  MTHFD1 regulates nuclear de novo thymidylate biosynthesis and genome stability. , 2016, Biochimie.

[229]  M. Brown,et al.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[230]  E. Y. Kim,et al.  SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy. , 2015, Journal of molecular and cellular cardiology.

[231]  D. Maric,et al.  Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage , 2011, PloS one.

[232]  J. Iñiguez-Lluhí,et al.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. , 2008, Molecular endocrinology.

[233]  Xiang-Jiao Yang,et al.  Sumoylation of Krüppel-like Factor 4 Inhibits Pluripotency Induction but Promotes Adipocyte Differentiation* , 2013, The Journal of Biological Chemistry.

[234]  Alice Barateau,et al.  The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy. , 2015, Human molecular genetics.

[235]  P. Stover Physiology of folate and vitamin B12 in health and disease. , 2004, Nutrition reviews.

[236]  N. Faresse Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances? , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[237]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[238]  M. Caudill,et al.  A UV-responsive Internal Ribosome Entry Site Enhances Serine Hydroxymethyltransferase 1 Expression for DNA Damage Repair* , 2009, The Journal of Biological Chemistry.

[239]  R. Hipskind,et al.  Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation , 2005, Molecular and Cellular Biology.

[240]  W. Paschen,et al.  Transient Global Cerebral Ischemia Induces a Massive Increase in Protein Sumoylation , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[241]  J. Hallenbeck,et al.  Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose , 2016, Journal of neurochemistry.

[242]  H. Shibata,et al.  The SUMO Conjugating Enzyme Ubc9 is a Regulator of GLUT4 Turnover and Targeting to the Insulin-Responsive Storage Compartment in 3T3-L1 Adipocytes , 2007, Diabetes.

[243]  M. Mcentee,et al.  Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk. , 2011, Cancer research.

[244]  W. Paschen,et al.  Cerebral ischemia/stroke and small ubiquitin‐like modifier (SUMO) conjugation – a new target for therapeutic intervention? , 2008, Journal of neurochemistry.

[245]  F. Tesson,et al.  Lamin A/C Mutants Disturb Sumo1 Localization and Sumoylation in Vitro and in Vivo , 2012, PloS one.

[246]  F. Polleux,et al.  AMP-activated protein kinase mediates mitochondrial fission in response to energy stress , 2016, Science.